David Pernock

2019 - Eagle Pharmaceuticals

In 2019, David Pernock earned a total compensation of $3.2M as President and Chief Operating Officer at Eagle Pharmaceuticals, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$681,100
Option Awards$1,003,778
Salary$567,582
Stock Awards$886,160
Other$33,805
Total$3,172,425

Pernock received $1M in option awards, accounting for 32% of the total pay in 2019.

Pernock also received $681.1K in non-equity incentive plan, $567.6K in salary, $886.2K in stock awards and $33.8K in other compensation.

Rankings

In 2019, David Pernock's compensation ranked 3,853rd out of 13,971 executives tracked by ExecPay. In other words, Pernock earned more than 72.4% of executives.

ClassificationRankingPercentile
All
3,853
out of 13,971
72nd
Division
Manufacturing
1,389
out of 5,701
76th
Major group
Chemicals And Allied Products
489
out of 2,200
78th
Industry group
Drugs
413
out of 1,886
78th
Industry
Pharmaceutical Preparations
314
out of 1,398
78th

Pay ratio

David Pernock's Pay$3,172,425
Median Employee's Pay$245,751
Pay Ratio

13

to 1

In 2019, the annual total compensation of David Pernock was $3,172,425.

The annual total compensation of the median employee at Eagle Pharmaceuticals was $245,751.

The ratio of David Pernock's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 29, 2020.

Pernock's colleagues

We found three more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2019.

2019

Scott Tarriff

Eagle Pharmaceuticals

Chief Executive Officer

2019

Pete Meyers

Eagle Pharmaceuticals

Chief Financial Officer

2019

Adrian Hepner

Eagle Pharmaceuticals

Chief Medical Officer

News

You may also like